Recent studies using models of kidney injury have associated the adenosine A3 receptor (ADORA3) with the progression of cellular events conducting to renal fibrosis, which can be reversed after the use of a receptor antagonist [29,30], which would be particularly relevant when the ligand levels are increased, as is the case of DN [27,31]. This evidence concerns the gene ADORA3 and liver dysplastic nodule.